title: Zinc modulates the innate immune response in vivo to polymicrobial sepsis through regulation of NF-kappaB.
abstract: Zinc is an essential element that facilitates coordination of immune activation during the host response to infection. We recently reported that zinc deficiency increases systemic inflammation, vital organ damage, and mortality in a small animal model of sepsis. To investigate potential mechanisms that cause these phenomena, we used the same animal model and observed that zinc deficiency increases bacterial burden and enhances NF-kappaB activity in vital organs including the lung. We conducted further studies in the lung to determine the overall impact of zinc deficiency. At the molecular level, NF-kappaB p65 DNA-binding activity was enhanced by zinc deficiency in response to polymicrobial sepsis. Furthermore, expression of the NF-kappaB-targeted genes IL-1beta, TNFalpha, ICAM-1, and the acute phase response gene SAA1/2 were elevated by zinc deficiency. Unexpectedly, the amount of NF-kappaB p65 mRNA and protein was increased in the lung including alveolar epithelia of zinc-deficient mice. These events occurred with a significant and concomitant increase in caspase-3 activity within 24 h of sepsis onset in zinc-deficient mice relative to control group. Short-term zinc supplementation reversed these effects. Reconstitution of zinc deficiency in lung epithelial cultures resulted in similar findings in response to TNFalpha. Taken together, zinc deficiency systemically enhances the spread of infection and NF-kappaB activation in vivo in response to polymicrobial sepsis, leading to enhanced inflammation, lung injury, and, as reported previously, mortality. Zinc supplementation immediately before initiation of sepsis reversed these effects thereby supporting the plausibility of future studies that explore zinc supplementation strategies to prevent sepsis-mediated morbidity and mortality.
authors.affiliation: Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA.
authors.forename: Shengying
authors.initials: S
authors.lastname: Bao
authors.forename: Ming-Jie
authors.initials: MJ
authors.lastname: Liu
authors.forename: Bryan
authors.initials: B
authors.lastname: Lee
authors.forename: Beth
authors.initials: B
authors.lastname: Besecker
authors.forename: Ju-Ping
authors.initials: JP
authors.lastname: Lai
authors.forename: Denis C
authors.initials: DC
authors.lastname: Guttridge
authors.forename: Daren L
authors.initials: DL
authors.lastname: Knoell
mesh_terms: D000818:Animals; D053148:Caspase 3 / Q000378:metabolism; D002432:Cecum; D002460:Cell Line; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects* / Q000502:physiology; D008026:Ligation; D008168:Lung / Q000276:immunology / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D016328:NF-kappa B / Q000502:physiology*; D011014:Pneumonia / Q000209:etiology / Q000503:physiopathology; D011677:Punctures; D018805:Sepsis / Q000276:immunology / Q000503:physiopathology*; D000685:Serum Amyloid A Protein / Q000096:biosynthesis; D051996:Transcription Factor RelA / Q000096:biosynthesis*; D015032:Zinc / Q000172:deficiency / Q000494:pharmacology*
chemical_list: D016328:NF-kappa B; C489995:Saa2 protein, mouse; D000685:Serum Amyloid A Protein; D051996:Transcription Factor RelA; D053148:Caspase 3; D015032:Zinc